Designed to provide reduced downtime and superior ease of use…
…the Q10 purchase is the most effective route to a safe patient environment.
Proven advantages of BIOQUELL technology
BIOQUELL is the leading room sterilisation technology:
The DoH Rapid Review Panel, which assessed the usefulness of novel technologies is combating HCAI, concluded that BIOQUELL is the only technology which merits a category 1 approval, i.e “should be available to NHS bodies”. Further, BIOQUELL was awarded the HCAI technology innovation award for “Best Technology against C.diff”
Reduce Healthcare Associated Infection (HCAI) rates:
BIOQUELL is the only room sterilisation technology to show reductions in HCAI rates.
Gold Standard efficacy:
BIOQUELL uses vapour to achieve 3-D kill, and the system has been developed to achieve 6 log reduction on endospore forming bacteria (e.g. C.diff)
Full cycle monitoring and data capture:
BIOQUELL equipment monitors environmental parameters during each cycle, validating and recording the efficacy of each cycle.
Residue free:
BIOQUELL’s technology catalyses and breaks down the hydrogen peroxide to oxygen and water vapour. Rooms require no further treatment after bioquelling is complete.
Health and Safety Characteristics:
Health and Safety monitoring equipment allows users to ensure the safety of staff and patients. This monitoring equipment is also used to release the room for re-occupation, ensuring that patients and staff can immediately enter the room without being exposed to peroxide levels above the Work Exposure Limit (WEL).
Excellent material compatibility:
BIOQUELL’s technology has now been used in hospitals for over five years with no material compatibility issues, even on sensitive electronic equipment.
Sterilise privacy curtains in situ:
The technology eliminates the need to remove, launder and replace privacy and shower curtains, saving time and money.
Sterilise equipment in hospital rooms:
Items of portable medical equipment are far more difficult to manually clean than flat surfaces, and, as high-touch sites, they are not potentially important reservoirs for pathogens. Further, not only is the responsibility for cleaning these items often not clearly specified, but even where responsibility is defined, many of the pieces of equipment are incompatible with products containing bleach and other chemical disinfectants. By contrast, BIOQUELL’s unique combination of 3-D distribution and excellent materials compatibility allows the hospitals to leave, or place, these problematic items in rooms undergoing sterilisation.
Benefits of the BIOQUELL Q-10 suite
Cost-benefit:
Having purchased the equipment, the cost per room sterilisation is minimised, allowing the hospital to realise rapid return on investment.
Reduced downtime:
Double distribution airflow results in faster sterilisation, and new catalyst technology results in rapid aeration time. Rooms are completed in approximately 2 hours*.
Improved user efficiency:
Equipment weight and size is designed for manoeuvrability and ease of use. Intuitive control interface facilitates a fast set-up time.
* depending on room size, materials and starting environmental conditions.
|
